Lucid Diagnostics Inc. (LUCD)
NASDAQ · Healthcare
Lucid Diagnostics Inc. Shareholder Equity 2021–2025
Lucid Diagnostics Inc. annual shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lucid Diagnostics Inc. shareholder equity as of December 31, 2025: 10.9M, a 102.86% increase year-over-year.
- Lucid Diagnostics Inc. shareholder equity for 2025 were 10.9M, a 102.86% increase from 2024.
- Lucid Diagnostics Inc. shareholder equity for 2024 were 5.4M, a 333.28% decrease from 2023.
- Lucid Diagnostics Inc. shareholder equity for 2023 were -2.3M, a 110.03% decrease from 2022.
- Lucid Diagnostics Inc. shareholder equity for 2022 were 23.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lucid Diagnostics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $11 |
| 2024 | $5 |
| 2023 | $-2 |
| 2022 | $23 |
| 2021 | $55 |
Lucid Diagnostics Inc. Shareholder Equity — FAQ
Lucid Diagnostics Inc. (LUCD) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LUCD's shareholder equity history?
The chart and table above show Lucid Diagnostics Inc.'s shareholder equity by year and by quarter, including the growth rate.